United States · FDA National Drug Code directory
Firdapse
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69616-211_4f94edd2-b6a8-264d-e063-6294a90a89df
- Product NDC
- 69616-211
- Form
- TABLET
- Composition / generic term
- amifampridine phosphate
- Labeler
- Catalyst Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190107
- Source listing expiry
- 20271231
Source-listed ingredients
- AMIFAMPRIDINE PHOSPHATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 240 TABLET in 1 BOTTLE, PLASTIC (69616-211-03) · 69616-211-03
- 12 BLISTER PACK in 1 CARTON (69616-211-06) / 10 TABLET in 1 BLISTER PACK (69616-211-04) · 69616-211-06
- 60 TABLET in 1 BOTTLE, PLASTIC (69616-211-08) · 69616-211-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →